About Us

Bactest was founded to exploit the clear market potential for a new type of automated blood culture instrument which responds to changing healthcare practices and safety issues. Existing machines are unable to respond to point of care needs within a market where services are increasingly centralised.

Of particular concern was the clear unmet need for advanced safety features and procedures to combat the rapid rise in HIV and other viral Infections when handling blood samples while testing.

The result has been the development of a microbial contamination testing technology platform featuring rapid detection with all the benefits of the existing automated system but in a small, portable, low power unit incorporating advanced, state of the art components and materials.

The Bactest DUOBAC automated blood culture instrument now unveiled in the Human Healthcare arena under the Gemini Diagnostics Brand is the first of a range of application launches and has been enthusiastically received by microbiology practitioners who believe that it is ideally positioned to meet the future demands of the diagnostics market.

The board of Directors has been significantly strengthened with the addition of two top executives who are spearheading Human Health applications within Bactest's new operating Company, Gemini Diagnostics Ltd


Tell me more about DUOBAC


Tell me more about recent appointments


Tell me more about Gemini Diagnostics

"The company have used a wide range of consultants and industry experience to identify a real need in blood cultures which no existing instrument can meet and have not only delivered DUOBAC, capable of uniquely meeting market demands but have also delivered an exciting technology platform with phenomenal applications and potential".

Alan Barrell ex CEO Baxter Healthcare UK and recipient of the Queen’s award for enterprise.
Contact Us